According to the Zhitong Finance App, Fosun Pharmaceutical (02196) announced that on November 2, 2026, it would spend about HK$33.237 million to repurchase 2 million shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.